American International Group, Inc. Eloxx Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.35 - $3.36 $20,965 - $52,180	-15,530 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$3.02 - $4.54 $123 - $186	41 Added 0.26%	15,530 $52,000
Q4 2020 Feb 12, 2021	SELL	$2.42 - $4.48 $1,076 - $1,993	-445 Reduced 2.79%	15,489 $62,000
Q3 2020 Nov 04, 2020	SELL	$2.53 - $3.4 $918 - $1,234	-363 Reduced 2.23%	15,934 $42,000
Q2 2020 Aug 12, 2020	BUY	$1.56 - $3.65 $2,190 - $5,124	1,404 Added 9.43%	16,297 $49,000
Q1 2020 May 04, 2020	SELL	$1.96 - $7.96 $1,687 - $6,853	-861 Reduced 5.47%	14,893 $29,000
Q4 2019 Feb 05, 2020	SELL	$3.19 - $7.56 $424 - $1,005	-133 Reduced 0.84%	15,754 $116,000
Q3 2019 Nov 08, 2019	BUY	$4.37 - $9.91 $6,367 - $14,438	1,457 Added 10.1%	15,887 $72,000
Q2 2019 Aug 13, 2019	BUY	$8.77 - $12.49 $1,122 - $1,598	128 Added 0.89%	14,430 $144,000
Q1 2019 May 06, 2019	SELL	$10.45 - $13.94 $4,838 - $6,454	-463 Reduced 3.14%	14,302 $167,000
Q4 2018 Feb 13, 2019	SELL	$10.43 - $17.39 $1,189 - $1,982	-114 Reduced 0.77%	14,765 $177,000
Q3 2018 Nov 09, 2018	BUY	$11.95 - $19.63 $10,360 - $17,019	867 Added 6.19%	14,879 $254,000
Q2 2018 Aug 08, 2018	BUY	$8.75 - $23.27 $122,605 - $326,059	14,012 New	14,012 $239,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.